Home › Meningioma
Pag-aaral pangklinika para sa Meningioma na nagre-recruit sa U.S.
29 pag-aaral para sa Meningioma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Miami, FL8 pag-aaral
- New York City, NY8 pag-aaral
- Columbus, OH7 pag-aaral
- Boston, MA7 pag-aaral
- San Francisco, CA6 pag-aaral
- Atlanta, GA6 pag-aaral
- Jacksonville, FL5 pag-aaral
- San Diego, CA5 pag-aaral
- Detroit, MI4 pag-aaral
- St. Louis, MO4 pag-aaral
- Milwaukee, WI4 pag-aaral
- Arlington, VA4 pag-aaral
- Los Angeles, CA4 pag-aaral
- Phoenix, AZ4 pag-aaral
- Houston, TX4 pag-aaral
- Nashville, TN3 pag-aaral
- Cleveland, OH3 pag-aaral
- Chicago, IL3 pag-aaral
- Omaha, NE3 pag-aaral
- Seattle, WA3 pag-aaral
- Grand Rapids, MI3 pag-aaral
- Rochester, MN3 pag-aaral
- Durham, NC3 pag-aaral
- Baltimore, MD3 pag-aaral
- Cedar Rapids, IA3 pag-aaral
- Cincinnati, OH3 pag-aaral
- Louisville, KY3 pag-aaral
- Minneapolis, MN3 pag-aaral
- Tampa, FL3 pag-aaral
Ayos sa estado
- Arizona4 pag-aaral
- California13 pag-aaral
- Connecticut3 pag-aaral
- Florida8 pag-aaral
- Georgia6 pag-aaral
- Illinois3 pag-aaral
- Indiana3 pag-aaral
- Iowa4 pag-aaral
- Kentucky4 pag-aaral
- Maryland5 pag-aaral
- Massachusetts7 pag-aaral
- Michigan5 pag-aaral
- Minnesota5 pag-aaral
- Missouri4 pag-aaral
- Nebraska3 pag-aaral
- New Hampshire4 pag-aaral
- New Jersey3 pag-aaral
- New York10 pag-aaral
- North Carolina5 pag-aaral
- Ohio8 pag-aaral
- Pennsylvania4 pag-aaral
- Tennessee4 pag-aaral
- Texas5 pag-aaral
- Virginia4 pag-aaral
- Washington3 pag-aaral
- Wisconsin5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT03180268UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT04343157A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07428616Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06955169Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04374305Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT02523014Natural History Study of Patients With Neurofibromatosis Type 2
Nagre-recruitObservasyonal na pag-aaral
Edad 8 hanggang 75 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT00598351Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06557512Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06014905RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07150806A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07533942Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04427384Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Nagre-recruitPhase 1/2
Edad 4 hanggang 39 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT05278208Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT07493447Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT05576103Cognitive Status After Removal of Skull Base Meningioma
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update May 22, 2026 · NCT04635657Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update May 19, 2026 · NCT07418775Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Nagre-recruitPhase 1/2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update May 14, 2026 · NCT05636618Cabozantinib for Patients With Recurrent or Progressive Meningioma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT05425004Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT04082520Abemaciclib in Newly Diagnosed Meningioma Patients
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05940493Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
Nagre-recruitPhase 4
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT06377371Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT04278118Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 10, 2026 · NCT06132685Evaluation of the CONVIVO System
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 6, 2026 · NCT05139277Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.